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Screening diabetic transplant candidates for coronary artery disease:
Identffication of a low risk subgroup. Coronary artery disase is the
major cause of death in diabetic renal transplant recipients. Because
one-third of diabetic transplant candidates have clinically silent coro-
nary artery disease, many transplant centers recommend coronary
angiography prior to transplantation. However, angiography is expen-
sive and may precipitate acute renal failure. Therefore, we developed a
noninvasive screening algorithm to identify patients at low risk for
coronary artery disease (CAD), defined as one or more coronary
stenoses 50% diameter. We performed coronary angiography in 141
consecutive asymptomatic Caucasian type I diabetic renal transplant
candidates. Fourteen of 16 patients age 45 or older had CAD. One
hundred and twenty-five patients under age 45 were randomly divided
into two groups. Ninety patients were used to identify clinical factors
significantly associated with CAD which included smoking for five or
more pack years, nonspecific ST-T wave changes on electrocardio-
gram, and diabetes duration 25 years or longer. The screening algo-
rithm, "CAD is predicted in diabetic transplant candidates under age 45
with any of the above risk factors," was then tested in the remaining 35
patients and in 35 additional patients. In these 70 patients, the algorithm
had a sensitivity of 97% and a negative predictive accuracy of 96%. We
conclude that coronary angiography should be recommended to Cau-
casian type I diabetic renal transplant candidates age 45 or older
because of the high probability of disease. In patients younger than 45
without a smoking history, ST-T wave changes on EKG, or diabetes
longer than 25 years, the likelihood of CAD is low and angiography can
be avoided.
Diabetic renal transplant candidates have a high prevalence
of coronary artery disease. Between 25 and 40% of asymptom-
atic patients screened with coronary angiography prior to renal
transplantation have been found to have a significant stenosis
(50 to 70%) in one or more coronary arteries [1—31. Two year
survival of patients with unrevascularized coronary stenoses is
less than 50% [2, 4—6]. After renal transplantation, coronary
artery disease remains the major cause of death in diabetic
patients [7, 8].
We recently demonstrated that revascularization of coronary
stenoses greater than 75% in diameter decreases short-term
cardiac morbidity and mortality of diabetic transplant candi-
dates [9]. Many centers now recommend pretranspiant coro-
nary angiography for most diabetic transplant candidates [6, 8,
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101. However, angiography is expensive and may precipitate
acute renal failure [11]. Therefore, a noninvasive screening
method is desirable to identify patients at low risk who do not
need pre-transplant coronary angiography. The use of chest
pain alone to screen diabetic patients for coronary artery
disease is inadequate because of the high prevalence of silent
ischemia in this population [12]. Both the exercise thallium and
dipyridamole-thallium tests have unacceptably low sensitivity
in diabetic patients with chronic renal failure [13—17]. There-
fore, we developed and tested a clinical algorithm to screen
diabetic renal transplant candidates for coronary artery disease.
To determine clinical predictors associated with severe cor-
onary artery disease, we studied diabetic patients undergoing
coronary angiography as part of an evaluation for renal trans-
plantation. We found that age was the major predictor of
disease. The prevalence of coronary artery disease (CAD),
defined as one or more coronary artery stenoses 50% or greater
in diameter, was so high (88%) in patients over age 45 that
coronary angiography was deemed advisable in that age group.
Of the remaining 125 patients under age 45, we studied 90
patients to determine the clinical predictors associated with
CAD. We then used multiple logistic regression analysis to
develop a clinical algorithm to identify a subset of patients at
low risk of CAD, in whom coronary angiography could be
avoided. We tested this algorithm in the remaining 35 patients
younger than 45 years of age, and in the next 35 consecutive
asymptomatic diabetic patients presenting for pretransplant
evaluation.
Methods
Patient selection and evaluation
All insulin-dependent diabetic patients referred to the Uni-
versity of Minnesota for consideration of renal transplantation
between February 1987 and March 1991 were eligible for this
study if they met these criteria: diabetes onset before age 31, a
measured creatinine clearance less than 25 mllmin, absence of
chest pain and no previous myocardial infection or coronary
bypass surgery. In all cases, angiography was performed as part
of routine pre-transplant screening and not for the evaluation of
chest pain. Patients were interviewed to obtain data about
previous hospitalizations, smoking habits, medications, diabe-
tes onset age, dialysis history, hypertension history, and family
history of myocardial infarction. Patients were examined for
evidence of carotid or femoral bruits. Blood pressure was taken
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Fig. 1. Prevalence of coronary artery disease in 141 asymptomatic
insulin-dependent diabetic patients with nephropathy.
in the seated position upon admission. Family history of pre-
mature myocardial infarction was defined as a myocardial
infarction or cardiac death occurring in a first-degree relative
before the age of 55. Hypertension onset was defined as the date
the patient was placed on antihypertensive medication. The
number of pack years of smoking was calculated as the product
of number of years smoked and number of packs smoked per
day. A history of congestive heart failure was diagnosed if one
of the following was present: (1) chest radiograph evidence of
interstitial fluid accumulation; (2) two pillow orthopnea; (3)
paroxysmal nocturnal dyspnea; (4) hospitalization for shortness
of breath in association with volume expansion. Electrocardio-
grams were evaluated for evidence of myocardial infarction, left
ventricular hypertrophy, and abnormal ST-T segments. Myo-
cardial infarction was coded as present if significant Qwaves
were present. Left ventricular hypertrophy was coded as
present if the voltage on electrocardiography met either the
criteria of Sokolow and Lyon [18] or Romhill and Estes [19].
ST-T segment abnormality was coded as present if any of the
following were seen: ST-T segment elevation or depression  1
mm, or inverted T-waves in any lead where the QRS-complex
had a net positive deflection. No patient had left or right bundle
branch block.
Coronary arteriography
Coronary arteriography was performed via the right femoral
artery. Multiple views of each coronary artery were recorded
using cineangiography. Each angiogram was independently
reviewed by two experienced angiographers who were blinded
to the clinical data and uninvolved in patient management. The
coronary artery tree was divided into 17 segments, each of
which was evaluated for the presence of coronary artery
stenosis using a scale of < 25%, 25—49%, 50—74%, 75—90%,
> 90% and 100%. CAD was defined as the presence of one or
more coronary arteries with 50% or greater diameter stenosis.
There was agreement of the readers regarding the presence or
absence of CAD on all ifims except one. This film was reviewed
by a third cardiologist and assigned to the CAD group.
No
stenosis  50%
(N=52)
Stenosis  50%
(N=38) P
Age years 34 6 36 6 0.09
Years diabetic 20 (17, 23) 25 (21, 31) <0.01
Male sex 33 (58) 20 (53) 0.39
Systolic blood pressure 151 27 154 22 0.52
Diastolic blood pressure 86 II 87 15 0.72
Cholesterol mg/dl 223 56 233 55 0,46
HDL cholesterol mg/d! 34.5 (29, 45) 31(27.5, 38) 0.19
Congestive heart failure 9(17) 4(11) 0.55
Smoking 5 pack years 19 (37) 23 (61) 0.03
Hypertension 5 years 17 (35) 14 (23) 0.20
Family history of Ml 9 (17) 10 (26) 0.31
Vascular bruit 6 (12) 7 (18) 0.38
Claudication 6 (12) 5 (13) 0.99
Previous cerebrovascular 3 (6) 5 (13) 0.27
accident
Previous amputation 3 (6) 0 (0) 0.26
Abnormal ST-T 4 (8) 13 (34) <0.01
segments
Table 2. Factors predictive of coronary artery stenosis 50%:
logistic regression analysis
95%
Variable Unit
Relative
odds
Confidence
interval P value
Abnormal ST-T segments present
Smoking 5 pack years present
Years diabetic 5 years
5.7
2.4
1.6
1.5—21.5
0.9—6.4
1.2—2.0
<0.05
0.08
<0.01
For definition of variables, see text.
Study design and statistical analysis
Because coronary atherosclerosis is strongly correlated with
age, patients were grouped in five-year age intervals and the
prevalence of CAD was tabulated (Fig. I). The prevalence of
CAD was so high after age 45 that coronary angiography could
be recommended using age criteria alone. The remaining 125
study patients under age 45 were randomly divided into two
groups. Ninety patients were used to determine clinical factors
predictive of CAD and to develop a screening algorithm for it.
Factors potentially predictive of CAD were compared in pa-
tients with and without CAD (Table I). Means and standard
deviations were determined for continuous variables and com-
pared using the two-sample T-test. When the distribution was
not normal, median values were compared using the Wilcoxon
Rank Sum test. Chi square analysis was used to test the
difference between dichotomous variables.
To test for independent predictive value of the associated
clinical factors, a stepwise logistic regression analysis was
performed using all variables (Table 2). The CAD screening
algorithm was derived from this analysis. The remaining 35
patients whose data had been set aside were used as a test
sample to evaluate the sensitivity, specificity and negative
predictive accuracy of the algorithm. Thirty-five additional
100.0
80.0
E 60.0
a)
C.)
a)0 40.0
20.0
0.0
Table 1. Factors potentially predictive of one or more coronary
stenoses  50% in insulin-dependent diabetic patients younger than
age 45 with chronic renal failure: univariate analysis
Values are expressed as median (25th percentile, 75th percentile) or
as number (percent). Family history = premature myocardial infarction
in a first degree relative.
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Table 3. Use of a clinical algorithm as a screening test for coronary
artery disease (CAD)
CAD
present
CAD
absent
CAD predicted 33 14
CAD not predicted 1 22
The algorithm tested was: "CAD is predicted in type I diabetic renal
transplant candidates less than 45 years old with abnormal ST-T
segments on EKG, smoking 5 or more pack years, or diabetes for at
least 25 years."
consecutive asymptomatic diabetic patients who presented for
pretransplant evaluation between April 1991 and September
1992 were also included in the test sample.
Results
Determination of predictors of coronary artery stenosis
Data from the first 141 patients screened revealed that the
prevalence of CAD increased with age (Fig. 1). Fourteen of 16
patients age 45 or older had CAD. Because of this high
prevalence rate, all type I diabetic patients age 45 or older were
assigned to have coronary angiography recommended prior to
renal transplantation.
To develop a screening algorithm for patients less than 45
years of age, univariate analysis was performed to determine
clinical factors associated with CAD (Table 1). Years of diabe-
tes, smoking five or more pack years, and abnormal ST-T
segments not attributable to LVH on electrocardiogram were
significantly associated with coronary artery disease. Logistic
regression analysis verified the independence of these three
factors. Patients with ST-T segment abnormalities were 5.7
times more likely to have CAD than patients without them
(Table 2). Smoking five or more pack years increased the odds
of CAD by a factor of 2.4. For every five years of diabetes, the
relative odds of CAD increased by a factor of 1.6.
Assessment of screening protocol for CAD
Using predictors identified from the first 90 patients, CAD
was predicted in diabetic patients with nephropathy less than 45
years old who had any of the following characteristics: ST-T
segment abnormalities on EKG, smoking five or more pack
years, or diabetes of at least 25 years duration.
The algorithm was tested using the test sample of 70 patients
whose data was not used to develop the algorithm. CAD was
present in 34 and absent in 36 test sample patients. CAD was
predicted in 47 patients, of whom 33 had CAD (Table 3). CAD
was predicted to be absent in 23 patients and was absent in 36.
CAD was predicted to be absent in only one patient with
disease. The sensitivity and negative predictive accuracy were
97% and 96%, respectively. However, the specificity and pos-
itive predictive accuracy were only 61% and 70%, respectively.
Discussion
The main finding of this study of diabetic renal transplant
candidates was the identification of a population unlikely to
have CAD, in whom coronary angiography was not useful prior
to renal transplantation. Insulin dependent diabetic patients
younger than age 45 who did not have EKG ST-T segment
abnormalities, had less than a five pack year smoking history,
and had not been diabetic longer than 25 years, were at low risk
for CAD. Therefore, patients meeting these criteria may not
need pretransplant coronary angiography. However, patients
aged 45 or older had an 88% prevalence of CAD. In these
patients, pre-transplant coronary angiography can be recom-
mended on the basis of age alone.
Although we were able to define a strategy for screening type
I diabetic transplant candidates which identified the majority of
low risk patients, this study has a number of limitations. First,
the number of patients in the test sample was relatively small.
Therefore, it is possible that the clinical algorithm may not be as
accurate as determined. Second, the study population was
limited to Caucasian type I diabetic patients. Therefore, the
results may not be applicable to Black patients or those with
noninsulin dependent diabetes. The third limitation is the use of
visual interpretation of the coronary angiograms. The limita-
tions of qualitative visual estimates of percent stenosis to
characterize coronary artery disease severity are well recog-
nized [201. However, the interobserver variability in this study
was extremely low. Furthermore, in most hospitals visual
analysis is used to determine patient management strategy and
may be more relevant to clinical practice than is quantitative
analysis. The fourth limitation is that our algorithm, although
useful as a screening test for coronary artery disease, is not
accurate at identifying patients with disease. In our study, 14 of
48 patients predicted to have disease did not have it. Therefore,
the algorithm can be used only to identify patients at low risk
for disease.
One-third asymptomatic of insulin-dependent diabetic pa-
tients screened with coronary angiography prior to renal trans-
plantation have one or more coronary artery stenoses greater
than 50 to 70% in diameter. The prognosis for these patients is
dismal, with up to 50% dying within two years [2, 4—6].
However, revascularization improves short-term survival and
decreases the incidence of myocardial infarction [9]. Therefore,
it is important to identify patients with severe coronary disease.
Although angina is the major clinical symptom prompting
coronary angiography in nondiabetic patients, it is an unreliable
screening test in diabetic patients because of the high preva-
lence of silent ischemia [121. Exercise thallium testing has a
sensitivity between 68 and 96% for the diagnosis of one or more
coronary stenoses greater than 50 to 70%, and is recommended
for screening patients with intermediate probability of disease
[21, 22]. However, many diabetic patients are unable to exer-
cise because of peripheral neuropathy or amputations. Even in
diabetic patients able to exercise, exercise thallium testing has
been shown to be unreliable because the majority of patients are
unable to achieve their target heart rate [14, 17].
Dipyridamole-thallium testing has been advocated as an
alternative when patients cannot exercise. However, data are
limited in diabetic patients with chronic renal failure. Two
investigators have reported sensitivities of 29% and 86% for
detection of coronary stenoses greater than 70% in this patient
population [14, 16]. Moreover, the higher sensitivity was re-
ported in a test population where 24% of patients with coronary
artery disease had had a previous myocardial infarction, which
may improve test sensitivity [23]. Dipyridamole-thallium testing
has also been evaluated for prediction of cardiovascular com-
plications rather than prediction of coronary artery stenosis.
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Two investigators have reported a sensitivity of 50% and 100%
[15, 24]. However, the higher sensitivity was reported in a study
group where only six patients had cardiovascular events, pre-
sumably because the follow-up time was as short as one month
for some patients [15]. Dipyridamole thallium testing may be
less accurate in diabetic patients with end-stage renal disease
because of the high prevalence of both left ventricular hyper-
trophy and balanced ischemia secondary to diffuse coronary
atherosclerosis in this population. A reduced coronary hyper-
emic response to adenosine has also been postulated [14]. In
summary, the limited data available regarding the efficacy of the
dipyridamole thallium test suggest that it may not be an
adequate screening test in diabetic patients with chronic renal
failure.
Using only clinical data and an EKG, we were able to identify
diabetic patients at low risk of CAD who could avoid the risks
associated with coronary angiography prior to renal transplan-
tation. We chose 50% as our cutoff for CAD, recognizing that
not all patients with this degree of stenosis would be eligible for
revascularization. Presumably this group of patients might
benefit from long-term strategies such as aggressive cholesterol
lowering to retard progression of atherosclerosis, and aspirin
therapy to reduce the risk of myocardial infarction. The clinical
algorithm used in this study compares favorably with the
reported utility of the dipyridamole thallium test. However,
further study is necessary to directly compare these screening
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